Professor Ann Morgan is a Consultant Rheumatologist and Head of the Molecular and Personalised Medicine Group within the Leeds Institute of Cardiovascular and Metabolic Medicine. She graduated from the University of Leeds and subsequently undertook a PhD studying Fcg Receptor genetics in rheumatoid arthritis, supported by the MRC.
Her main clinical interests are vasculitis and rare autoimmune diseases, and she leads the regional Behçets syndrome and large vessel vasculitis services. Ann has undertaken combined Rheumatology and Ophthalmology clinics for 15 years.
Her active research projects range from laboratory studies to analysis large epidemiological datasets and undertaking patient-focused research. She Chairs both the UK GCA Consortium and the MRC TARGET Partnership and is establishing an expanding research programme in vascular biology.